Towards targeting anticancer drugs: ruthenium(ii)–arene complexes with biologically active naphthoquinone-derived ligand systems-Reference-Cited by-同舟云学术

Towards targeting anticancer drugs: ruthenium(ii)–arene complexes with biologically active naphthoquinone-derived ligand systems

Published:2016 Issue:33 Volume:45 Page:13091-13103
ISSN:1477-9226
Container-title:Dalton Transactions
language:en
Short-container-title:Dalton Trans.

Author:

Kubanik Mario¹²³⁴,Kandioller Wolfgang⁵⁶⁷⁸⁹,Kim Kunwoo¹²³⁴,Anderson Robert F.¹²³⁴¹⁰,Klapproth Erik⁵⁶⁷⁸⁹,Jakupec Michael A.⁵⁶⁷⁸⁹,Roller Alexander⁵⁶⁷⁸⁹,Söhnel Tilo¹²³⁴,Keppler Bernhard K.⁵⁶⁷⁸⁹,Hartinger Christian G.¹²³⁴⁵

Affiliation:

1. University of Auckland

2. School of Chemical Sciences

3. Auckland 1142

4. New Zealand

5. University of Vienna

6. Faculty of Chemistry

7. Institute of Inorganic Chemistry

8. A-1090 Vienna

9. Austria

10. Auckland Cancer Society Research Centre

Abstract

2-Hydroxy-[1,4]-naphthoquinone-derived ligands and their Ru^II(η⁶-p-cymene)Cl complexes were prepared with the aim to obtain multimodal anticancer agents.

Publisher

Royal Society of Chemistry (RSC)

Subject

Inorganic Chemistry

Link

http://pubs.rsc.org/en/content/articlepdf/2016/DT/C6DT01110A

Reference59 articles.

1. Cisplatin in cancer therapy: Molecular mechanisms of action

2. Update of the Preclinical Situation of Anticancer Platinum Complexes: Novel Design Strategies and Innovative Analytical Approaches

3. A. V. Klein and T. W.Hambley, in Ligand Design in Medicinal Inorganic Chemistry, John Wiley & Sons, Ltd, 2014, pp. 9–45

4. Cisplatin as an Anti-Tumor Drug: Cellular Mechanisms of Activity, Drug Resistance and Induced Side Effects

5. Molecular mechanisms of resistance and toxicity associated with platinating agents

Cited by 51 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A multifaceted approach towards organometallic anticancer agent development;Journal of Organometallic Chemistry;2024-05

2. Unlocking the potential of 1,4-naphthoquinones: A comprehensive review of their anticancer properties;European Journal of Medicinal Chemistry;2024-03

3. A Multifaceted Approach Towards Organometallic Anticancer Agent Development;2024

4. Cytotoxic Imidazolyl-Mesalazine Ester-Based Ru(II) Complexes Reduce Expression of Stemness Genes and Induce Differentiation of Oral Squamous Cell Carcinoma;Journal of Medicinal Chemistry;2023-10-13

5. “Half-Sandwich” Ruthenium Complexes with Alizarin as Anticancer Agents: In Vitro and In Vivo Studies;Inorganic Chemistry;2023-04-26